From: Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study
Multivariate analysis | ||
---|---|---|
aOR (95% CI) | p-value | |
Sex | ||
Male | 1 | |
Female | 1.36 (1.28–1.45) | < 0.0001 |
Age (years) | ||
< 50 | 1 | |
50–54 | 1.21 (0.86–1.70) | < 0.0001 |
55–59 | 1.41 (1.03–1.93) | |
60–64 | 1.52 (1.10–2.09) | |
65–69 | 1.47 (1.07–2.02) | |
70–74 | 1.52 (1.10–2.10) | |
75–79 | 1.37 (0.99–1.90) | |
80–84 | 1.61 (1.16–2.23) | |
≥ 85 | 1.94 (1.40–2.69) | |
Charlson index | ||
0 | 1 | |
1–2 | 2.21 (1.11–4.41) | 0.0013 |
3–4 | 2.82 (1.40–5.68) | |
≥ 5 | 2.87 (1.42–5.80) | |
Non-invasive ventilation and/or oxygen therapy in 2017 | ||
No | 1 | |
Yes | 1.52 (1.41–1.64) | < 0.0001 |
Long-acting bronchodilator prescription in 2017 | ||
0 | 1 | |
1 | 1.13 (0.97–1.32) | 0.0038 |
2 | 1.18 (0.99–1.40) | |
3 | 1.17 (0.97–1.40) | |
≥ 4 | 1.19 (1.09–1.30) |